Formation Bio · 3 days ago
Vice President, Engineering
Formation Bio is a tech and AI driven pharma company focused on revolutionizing drug development. They are seeking a Vice President of Engineering to lead and transform their technical capabilities, ensuring that engineering efforts increase drug asset quality and value while collaborating closely with various teams to develop high-leverage technology solutions.
Artificial Intelligence (AI)BiotechnologyClinical TrialsHealth CareMedicalPharmaceutical
Responsibilities
Define and execute a technical vision that prioritizes high-leverage computational capabilities over traditional software features, ensuring engineering effort directly increases drug asset quality and value
Act as a core collaborator for the CTO and leadership team, translating complex clinical and business bottlenecks into scalable engineering solutions
Embed engineering resources within Business Development, Clinical, and R&D units to leverage technology to address operational needs
Partner with Data Science to build the engineering architecture required for complex analysis, including Real-World Evidence (RWE) platforms, asset screening frameworks, and prediction pipelines
Collaborate with Product to build specialized tools that streamline R&D workflows, moving the needle from manual efforts to technology-augmented insight generation
Develop and scale proprietary platforms for the ingestion and operationalization of external, clinical, and biological datasets
Ensure the delivery of GxP-validated clinical environments and automated security compliance, maintaining a regulatory-first posture without sacrificing speed
Deploy and scale LLM-integrated features and autonomous agents to drive multiplier efficiencies across the organization
Manage and mentor a specialized engineering organization, fostering a high-performance culture that values technical rigor, interdisciplinary collaboration, and mission-driven delivery
Refine the team structure to maintain high talent density and quality engineering in a fast-paced biotech environment
Qualification
Required
10+ years of experience in software/data engineering and technical leadership, with a significant background in the Boston biotech or pharma-tech ecosystem
You have likely been a VP of Engineering at 2–3 different biotechs and possess a deep understanding of the drug development lifecycle, from Discovery through Phase III
Experience managing and mentoring a team of 15+ engineers, with a track record of driving results in highly technical, interdisciplinary environments
You understand that we aren't building a 'user app'; we are building an engine for insights. You are passionate about the backend engineering required for RWE, data science, and trial automation
Deep expertise in building data ingestion pipelines and managing complex, heterogeneous biological and clinical datasets
Experience working within GxP (GCP, GLP, GMP) environments. You know how to build technical capabilities that are 'regulatory-ready' from day one
You are comfortable discussing risk-adjusted NPV, asset-level ROI, and clinical trial bottlenecks with CEOs, CMOs, and investors
Passionate about using hard engineering to solve the drug development bottleneck and bring life-changing treatments to patients faster
Benefits
Equity
Comprehensive benefits
Generous perks
Hybrid flexibility
Company
Formation Bio
Formation Bio is a drug development company that strives to provide treatments to patients faster by reimagining clinical trials.
H1B Sponsorship
Formation Bio has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (5)
Funding
Current Stage
Late StageTotal Funding
$528MKey Investors
Andreessen Horowitz
2024-06-26Series D· $372M
2021-09-30Series C· $156M
2018-10-15Series Unknown
Recent News
Spark Capital
2026-01-07
BioWorld Financial Watch
2025-12-19
2025-12-16
Company data provided by crunchbase